Cntf Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Ciliary neurotrophic factor (CNTF) is a neuroprotective cytokine belonging to the IL-6 family. It promotes the survival and differentiation of various neuronal populations and has been investigated as a potential therapeutic for neurodegenerative diseases including ALS, AD, and PD.
CNTF has a characteristic four-helix bundle cytokine structure:
- Primary Structure: 200 amino acids (precursor), 163 aa mature protein
- Fold: Four-helix bundle (up-up-down-down topology)
- Key Regions:
- Signal peptide: N-terminal secretion signal (1-26 aa)
- Receptor binding sites: Multiple sites for CNTFRα, gp130, LIFRβ
- Heparin binding domain: For extracellular matrix association
- Post-translational Modifications: N-glycosylation (minor)
CNTF mediates neuroprotective effects through multiple mechanisms:
- Neuronal Survival: Prevents apoptotic cell death in motor, sensory, and hippocampal neurons
- Differentiation: Promotes oligodendrocyte precursor differentiation
- Synaptic Plasticity: Modulates neurotransmitter function
- Anti-inflammatory: Reduces neuroinflammation through microglial modulation
- Astrocyte Function: Promotes astrocyte differentiation
- Neuroprotective for motor neurons
- Clinical trials showed modest effects
- AAV-mediated CNTF delivery in development
- Protects hippocampal neurons from Aβ toxicity
- Improves synaptic function in AD models
- Being explored as therapeutic agent
- Protects dopaminergic neurons
- Shows promise in MPTP models
- Delivery to midbrain is challenging
- Promotes oligodendrocyte differentiation
- Remyelination potential
- Being investigated in animal models
- Protects photoreceptor neurons
- Clinical trials using encapsulated cell therapy
| Drug/Agent |
Mechanism |
Status |
| Recombinant CNTF |
Neuroprotection |
Clinical trials (ALS, RP) |
| AAV-CNTF |
Gene therapy |
Preclinical/clinical |
| CNTF mimetics |
CNTFR agonist |
In development |
| Encapsulated cells |
CNTF delivery |
Clinical trials |
- Sendtner M, et al. (1992). CNTF and motor neuron survival. Nature.
- Ip NY, et al. (1993). CNTF signal transduction. Neuron.
- Azzouz M, et al. (2004). Gene therapy for ALS using CNTF. J Neurosci.
The study of Cntf Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.